Literature DB >> 20084552

Searching for new genetic risk factors for neuropsychiatric disorders in expression databases.

Manuela Barbosa Rodrigues de Souza1, Roberta Rodrigues de Lemos, José Eriton Gomes da Cunha, José Luiz de Lima Filho, João Ricardo Mendes de Oliveira.   

Abstract

Genetic variations might contribute to differences in protein activities and gene expression levels observed in complex genetic traits, like neuropsychiatric disease. This finding motivated the development of original approaches using expression studies to guide the finding of new genetic variations. We extended this approach to new genes selected from microarrays studies of brain samples of patients with Alzheimer's disease, major depressive disorder, bipolar affective disorder, and sporadic Creutzfeldt-Jakob disease. The CLCbio Workbench Combined version 3.6.2 was initially used to build expression sites tags (ESTs) and mRNA files retrieved, respectively, from the Goldenpath (UCSC) and NCBI databases and latter to perform multiple batches of Smith-Waterman alignments. The total of 438 ESTs sequences were selected after proper stringent parameters were applied to the first set of mismatches. The annotation revealed various classes of variations, most of them deletions ranging from 1 to 10 pb. These deletions were present in coding regions, 5' and 3' UTR regions. Deletions are often associated to major genetic syndromes with dysmorphic features; however, recent studies show that common microdeletions might be highly associated with common neuropsychiatric disorders.

Entities:  

Mesh:

Year:  2010        PMID: 20084552     DOI: 10.1007/s12031-009-9321-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

1.  High-throughput identification, database storage and analysis of SNPs in EST sequences.

Authors:  F J Useche; G Gao; M Harafey; A Rafalski
Journal:  Genome Inform       Date:  2001

2.  Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues.

Authors:  Ashani T Weeraratna; Audrey Kalehua; Isoke Deleon; Dorothy Bertak; Gregory Maher; Michael S Wade; Ana Lustig; Kevin G Becker; William Wood; Douglas G Walker; Thomas G Beach; Dennis D Taub
Journal:  Exp Cell Res       Date:  2006-11-01       Impact factor: 3.905

3.  Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease.

Authors:  C Ferrarese; L Tremolizzo; M Rigoldi; G Sala; B Begni; L Brighina; G Ricci; M G Albizzati; R Piolti; F Crosti; L Dalprà; L Frattola
Journal:  Neurol Sci       Date:  2001-02       Impact factor: 3.307

4.  Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.

Authors:  P V Choudary; M Molnar; S J Evans; H Tomita; J Z Li; M P Vawter; R M Myers; W E Bunney; H Akil; S J Watson; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

5.  Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.

Authors:  Tom Walsh; Jon M McClellan; Shane E McCarthy; Anjené M Addington; Sarah B Pierce; Greg M Cooper; Alex S Nord; Mary Kusenda; Dheeraj Malhotra; Abhishek Bhandari; Sunday M Stray; Caitlin F Rippey; Patricia Roccanova; Vlad Makarov; B Lakshmi; Robert L Findling; Linmarie Sikich; Thomas Stromberg; Barry Merriman; Nitin Gogtay; Philip Butler; Kristen Eckstrand; Laila Noory; Peter Gochman; Robert Long; Zugen Chen; Sean Davis; Carl Baker; Evan E Eichler; Paul S Meltzer; Stanley F Nelson; Andrew B Singleton; Ming K Lee; Judith L Rapoport; Mary-Claire King; Jonathan Sebat
Journal:  Science       Date:  2008-03-27       Impact factor: 47.728

Review 6.  The prion's elusive reason for being.

Authors:  Adriano Aguzzi; Frank Baumann; Juliane Bremer
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

7.  A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.

Authors:  Jeremy A Miller; Michael C Oldham; Daniel H Geschwind
Journal:  J Neurosci       Date:  2008-02-06       Impact factor: 6.167

8.  Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Simon Mead; Mark Poulter; James Uphill; John Beck; Jerome Whitfield; Thomas E F Webb; Tracy Campbell; Gary Adamson; Pelagia Deriziotis; Sarah J Tabrizi; Holger Hummerich; Claudio Verzilli; Michael P Alpers; John C Whittaker; John Collinge
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

9.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

10.  Identification and characterization of OGG1 mutations in patients with Alzheimer's disease.

Authors:  Guogen Mao; Xiaoyu Pan; Bei-Bei Zhu; Yanbin Zhang; Fenghua Yuan; Jian Huang; Mark A Lovell; Maxwell P Lee; William R Markesbery; Guo-Min Li; Liya Gu
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

View more
  5 in total

1.  Searching for new genetic variations in expression databases for the GABAergic and glutamatergic systems.

Authors:  Manuela Barbosa Rodrigues de Souza; João Ricardo Mendes de Oliveira
Journal:  J Mol Neurosci       Date:  2012-04-22       Impact factor: 3.444

Review 2.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

3.  Exploring the implications of INDELs in neuropsychiatric genetics: challenges and perspectives.

Authors:  R R Lemos; M B R Souza; J R M Oliveira
Journal:  J Mol Neurosci       Date:  2012-02-16       Impact factor: 3.444

4.  Retinal Nerve Fiber Layer Thickness Measurement by Spectral-Domain Optical Coherence Tomography in Patients with Major Depressive Disorder.

Authors:  İpek Sönmez; Ferdi Köşger; Ümit Aykan
Journal:  Noro Psikiyatr Ars       Date:  2017-03       Impact factor: 1.339

Review 5.  Chronic depression as a model disease for cerebral aging.

Authors:  Bettina H Bewernick; Thomas E Schlaepfer
Journal:  Dialogues Clin Neurosci       Date:  2013-03       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.